Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Detemir Extension in Children and Adolescents with Type 1 Diabetes
NCT00623194Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Feb 2008
- Primary completion
- Sep 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 11
01
Overview
A Phase 3 trial of insulin detemir in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Started Feb 2008; status: completed.
02
Drugs
insulin detemir
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00623194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00623194.